Sectors
NAMS
NewAmsterdam Pharma Company N.V.
25.25
2 x 19.66
2 x 33.17
bid
ask
-
0.65
2.51%
10:30 AM
timesize
| Ytd | -28.02% | |
| 1y | 4.99% |
25.11
day range
25.65
23.05
52 week range
42.20
| Open | 25.65 | Prev Close | 25.90 | Low | 25.11 | High | 25.65 | Mkt Cap | 2.95B |
| Vol | 75.37K | Avg Vol | 1.12M | EPS | -2.16 | P/E | N/A | Forward P/E | -16.49 |
| Beta | 0.10 | Short Ratio | 11.19 | Inst. Own | 105.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 30.23 | 200-d Avg | 32.88 | 1yr Est | 51.55 |
| Income Statement | |||
| Total Revenue | 3.70M | ||
| Revenues (USD) | 4.21M | ||
| Gross Profit | 3.70M | ||
| Operating Expenses | 68.57M | ||
| Research and Development Expense | 41.67M | ||
| Selling, General and Administrative Expense | 26.89M | ||
| Operating Income | -64.86M | ||
| Net Income | -64.14M | ||
| Net Income Common Stock | -64.14M | ||
| Net Income Common Stock (USD) | -72.88M | ||
| Consolidated Income | -64.14M | ||
| Earnings per Basic Share | -0.52 | ||
| Earnings per Basic Share (USD) | -0.59 | ||
| Earnings per Diluted Share | -0.52 | ||
| Earning Before Interest & Taxes (EBIT) | -64.14M | ||
| Earning Before Interest & Taxes (USD) | -72.88M | ||
| Weighted Average Shares | 116.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 425.51M | ||
| Cash and Equivalents (USD) | 483.53M | ||
| Investments | 254.11M | ||
| Investments Current | 209.70M | ||
| Investments Non-Current | 44.41M | ||
| Trade and Non-Trade Receivables | 24.00M | ||
| Current Assets | 659.21M | ||
| Property, Plant & Equipment Net | 493.00K | ||
| Total Assets | 704.45M | ||
| Debt Current | 26.00K | ||
| Total Debt | 82.00K | ||
| Current Liabilities | 72.97M | ||
| Debt Non-Current | 56.00K | ||
| Total Liabilities | 73.03M | ||
| Accumulated Retained Earnings (Deficit) | -874.97M | ||
| Accumulated Other Comprehensive Income | 3.86M | ||
| Shareholders Equity | 631.42M | ||
| Shareholders Equity (USD) | 717.53M | ||
| Assets Non-Current | 45.25M | ||
| Total Debt (USD) | 93.18K | ||
| Deferred Revenue | 2.80M | ||
| Goodwill and Intangible Assets | 343.00K | ||
| Liabilities Non-Current | 56.00K | ||
| Trade and Non-Trade Payables | 5.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 59.00K | ||
| Net Cash Flow from Financing | 11.04M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -32.93M | ||
| Capital Expenditure | -80.00K | ||
| Issuance (Purchase) of Equity Shares | 11.04M | ||
| Net Cash Flow from Investing | -4.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.68M | ||
| Net Cash Flow from Operations | -39.21M | ||
| Share Based Compensation | 18.38M | ||